衰弱作为头颈癌患者术后结局的预测因素
该回顾性横断面病例系列纳入2014年1月至2017年12月间410例头颈癌手术患者,计算改良衰弱指数与约翰霍普金斯调整临床组衰弱指数,并分析美国麻醉医师协会分级。改良衰弱指数评分显著增加死亡(比值比=1.475,P=.012)、再入院(比值比=1.472,P=.004)、住院时间(相对危险度=1.136,P=.001)及围术期并发症数量的风险;调整临床组指数不是显著预测因素。
要点
- 改良衰弱指数评分每增加,死亡比值比=1.475(P=.012)、再入院比值比=1.472(P=.004)。
- 改良衰弱指数评分与住院时间相关(相对危险度=1.136,P=.001)及围术期并发症数量增加。
- 美国麻醉医师协会分级也与再入院、住院时间和围术期并发症显著相关。
核心结论
- 在头颈癌手术患者中,改良衰弱指数评分较高与围术期不良结局和死亡风险显著增加相关。
研究设计与样本
- 回顾性横断面病例系列,带病历回顾,共查询410份病历,时间为2014年1月至2017年12月。
- 研究场所为学术三级医疗中心。
主要发现
- 死亡率为11%,平均住院时间为7.4±5.5天,再入院率为17%。
- 改良衰弱指数评分显著增加死亡风险(比值比=1.475,P=.012)和再入院风险(比值比=1.472,P=.004)。
- 改良衰弱指数评分显著增加住院时间(相对危险度=1.136,P=.001)和围术期并发症数量。
- 美国麻醉医师协会分级与再入院、住院时间和围术期并发症显著相关。
- 调整临床组指数在该研究人群中不是显著结局预测因素。
关键数值与推荐
- 改良衰弱指数评分与死亡:比值比=1.475,P=.012。
- 改良衰弱指数评分与再入院:比值比=1.472,P=.004。
- 改良衰弱指数评分与住院时间:相对危险度=1.136,P=.001。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To understand measures of frailty among preoperative patients and explain how these can predict perioperative outcomes among patients with head and neck cancer. STUDY DESIGN: Retrospective cross-sectional case series with chart review. SETTING: Academic tertiary medical center. SUBJECTS AND METHODS: A retrospective review was performed of patients presenting to an academic hospital following a surgical procedure for a head and neck cancer diagnosis. Charts were queried for preoperative medical diagnoses to calculate 2 frailty scores: the American College of Surgeons National Surgical Quality Improvement Program modified frailty index and the Johns Hopkins Adjusted Clinical Groups frailty index. The American Society of Anesthesiologists classification system was also analyzed as a predictor. Primary outcomes were mortality, 30-day readmission, and length of stay. Perioperative complications and discharge disposition were also evaluated. RESULTS: A total of 410 charts were queried between January 2014 and December 2017. Mortality was 11%; mean ± SD length of stay was 7.4 ± 5.5 days; and the readmission rate was 17%. The modified frailty index score significantly increased the odds of mortality (odds ratio = 1.475, P = .012) and readmission (odds ratio = 1.472, P = .004), the length of stay (relative risk = 1.136, P = .001), and the number of perioperative complications. The American Society of Anesthesiologists classification was also significantly associated with poor outcomes, including readmission, length of stay, and perioperative complications. The Adjusted Clinical Groups index was not a significant predictor of outcomes in this study population. CONCLUSIONS: This study demonstrated a significant increase in poor perioperative outcomes and mortality among patients with head and neck cancer and increased frailty, as measured by the modified frailty index.
引用
- Pitts KD, Arteaga AA, Stevens BP, et al. Frailty as a Predictor of Postoperative Outcomes among Patients with Head and Neck Cancer. Otolaryngol Head Neck Surg. 2019. PMID: 30691350. doi:10.1177/0194599818825466
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。